Filtros de búsqueda

Lista de obras de

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts: National Harbor, MD, USA. 9-13 November 2016.

artículo científico publicado en 2016

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

artículo científico publicado en 2016

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two: National Harbor, MD, USA. 9-13 November 2016

artículo científico publicado en 2016

A case of checkpoint inhibitor-induced celiac disease

artículo científico publicado en 2019

A patient with melanoma that became sensitized to immunotherapy after treatment with a CDK4/6 inhibitor

scientific article published on 09 July 2020

Age as a predictor of sentinel node metastasis among patients with localized melanoma: an inverse correlation of melanoma mortality and incidence of sentinel node metastasis among young and old patients

artículo científico publicado en 2014

Age as a prognostic factor in patients with localized melanoma and regional metastases

artículo científico publicado en 2013

Arterial Spin Labeled Perfusion MRI for the Evaluation of Response to Tyrosine Kinase Inhibition Therapy in Metastatic Renal Cell Carcinoma

artículo científico publicado en 2020

Association between Body Mass Index and Immune-Related Adverse Events (irAEs) among Advanced-Stage Cancer Patients Receiving Immune Checkpoint Inhibitors: A Pan-Cancer Analysis

scholarly article

Correction: Zhang et al. Association between Body Mass Index and Immune-Related Adverse Events (irAEs) among Advanced-Stage Cancer Patients Receiving Immune Checkpoint Inhibitors: A Pan-Cancer Analysis. 2021, , 6109

correction of a scholarly article

Current challenges for assessing the long-term clinical benefit of cancer immunotherapy: a multi-stakeholder perspective

artículo científico publicado en 2020

Defining the critical hurdles in cancer immunotherapy

artículo científico publicado en 2011

Diffuse pneumonitis from coronavirus HKU1 on checkpoint inhibitor therapy

scientific article published on 01 May 2020

Evolving impact of long-term survival results on metastatic melanoma treatment

artículo científico publicado en 2020

Future perspectives in melanoma research: meeting report from the "Melanoma Bridge": Napoli, December 3rd-6th 2014.

artículo científico publicado en 2015

Insights from immuno-oncology: the Society for Immunotherapy of Cancer Statement on access to IL-6-targeting therapies for COVID-19

artículo científico publicado en 2020

Melanoma and immunotherapy bridge 2015 : Naples, Italy. 1-5 December 2015

artículo científico publicado en 2016

Number of primary melanomas is an independent predictor of survival in patients with metastatic melanoma

artículo científico publicado en 2012

Outcomes of patients with metastatic melanoma treated with immunotherapy prior to or after BRAF inhibitors

artículo científico publicado en 2014

Phase II Study of Nivolumab and Salvage Nivolumab/Ipilimumab in Treatment-Naive Patients With Advanced Clear Cell Renal Cell Carcinoma (HCRN GU16-260-Cohort A)

artículo científico publicado en 2022

Standard-dose pembrolizumab in combination with reduced-dose ipilimumab for patients with advanced melanoma (KEYNOTE-029): an open-label, phase 1b trial.

artículo científico

Strategies for improving the management of immune-related adverse events

scientific article published on 01 December 2020

The society for immunotherapy of cancer consensus statement on immunotherapy for the treatment of advanced renal cell carcinoma (RCC)

scientific article published on 20 December 2019

The state of melanoma: challenges and opportunities

artículo científico publicado en 2016

What's new in melanoma? Combination!

artículo científico publicado en 2015

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda